EP4048260
SAMSETNING AF VALKVÆMT ÚTSKIPTUM 4-AMÍNÓÍSÓINDÓLÍN-1,3-DÍÓN EFNASAMBÖNDUM OG ÖÐRUM VIRKUM EFNUM TIL NOTKUNAR VIÐ MEÐFERÐ Á ILLKYNJA BLÓÐSJÚKDÓMI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.10.2020EP published:
11.3.2026EP application number:
20807561.4
EP translation filed:
4.5.2026Grant published:
10.6.2026EPO information:
European Patent Register
Max expiry date:
19.10.2040Expiry date:
19.10.2026
Title in English:
COMBINATION OF SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING A HEMATOLOGICAL MALIGNANCYLanguage of the patent:
English
Timeline
Today
20.10.2020EP application
11.3.2026EP Publication
4.5.2026Translation submitted
10.6.2026Registration published
19.10.2026Expires
Owner
Name:
Celgene CorporationAddress:
Route 206 & Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
ANTON, Maria Soraya CarrancioAddress:
San Diego, CA 92121, US
Name:
BUCHHOLZ, Tonia J.Address:
San Francisco, CA 94185, US
Name:
CHANG, HenryAddress:
San Francisco, CA 94185, US
Name:
FILVAROFF, EllenAddress:
San Francisco, CA 94185, US
Name:
KASIBHATLA, ShailajaAddress:
San Diego, CA 92121, US
Name:
LOPEZ-GIRONA, AntoniaAddress:
San Diego, CA 92121, US
Name:
MOHAN, AdithiAddress:
San Francisco, CA 94185, US
Name:
NARLA, Rama KrishnaAddress:
San Diego, CA 92121, US
Name:
POURDEHNAD, MichaelAddress:
San Francisco, CA 94185, US
Name:
PIERCEALL, William EdwardAddress:
Summit, NJ 07901, US
Name:
THAKURTA, AnjanAddress:
Summit, NJ 07901, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201962923945 PDate:
21.10.2019Country:
US
Classification
Categories:
A61K 31/4045, A61K 31/4184, A61K 31/436, A61K 31/4468, A61K 31/47, A61K 31/506, A61K 31/519, A61K 31/52, A61K 31/5377, A61K 31/55, A61K 31/551, A61K 31/635, A61K 31/675, A61K 31/706, A61K 31/7076, A61P 35/00